Quality of drug information for healthcare professionals: The ARCA acronym
Main Article Content
Keywords
Drug Information Services, Decision Support Systems, Clinical, Drug Labeling, Total Quality Management
Abstract
.
Downloads
Download data is not yet available.
References
1. Hawking SW. Information loss in black holes. Phys Rev. 2005;72(8)084013. doi: 10.1103/PhysRevD.72.084013
2. Sweeney KG. The information paradox. Occas Pap R Coll Gen Pract. 1998;(76):17-25.
3. Fernandez-Llimos F, Loza MI. Product monographs supplied by drug manufacturers to community pharmacists in Spain. Ann Pharmacother. 2000;34(3):407.
4. Bhaumik S, Pakenham-Walsh N, Chatterjee P, Biswas T. Governments are legally obliged to ensure adequate access to health information. Lancet Glob Health. 2013;1(3):e129-e130. doi: 10.1016/S2214-109X(13)70043-3
5. Royston G, Hagar C, Long LA, McMahon D, Pakenham-Walsh N, Wadhwani N; mHIFA Working Group (Mobile Healthcare Information For All). Mobile health-care information for all: a global challenge. Lancet Glob Health. 2015;3(7):e356-e357. doi: 10.1016/S2214-109X(15)00054-6
6. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi: 10.1136/bmj.39489.470347.AD
7. Lebanova H, Getov I, Grigorov E. Practical tool to assess reliability of web-based medicines information. Med Glas (Zenica). 2014;11(1):221-227.
8. Chalmers I. Underreporting research is scientific misconduct. JAMA. 1990;263(10):1405-1408.
9. Fernandez-Llimos F, Vazquez Gomez I. Information provided by generic and brand-name pharmaceutical manufacturers in response to a request. Pharm World Sci. 2007;29(6):683-687.
10. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207-216.
11. Arguello B, Salgado TM, Fernandez-Llimos F. Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation. Br J Clin Pharmacol. 2015;79(3):537-544. doi: 10.1111/bcp.12515
2. Sweeney KG. The information paradox. Occas Pap R Coll Gen Pract. 1998;(76):17-25.
3. Fernandez-Llimos F, Loza MI. Product monographs supplied by drug manufacturers to community pharmacists in Spain. Ann Pharmacother. 2000;34(3):407.
4. Bhaumik S, Pakenham-Walsh N, Chatterjee P, Biswas T. Governments are legally obliged to ensure adequate access to health information. Lancet Glob Health. 2013;1(3):e129-e130. doi: 10.1016/S2214-109X(13)70043-3
5. Royston G, Hagar C, Long LA, McMahon D, Pakenham-Walsh N, Wadhwani N; mHIFA Working Group (Mobile Healthcare Information For All). Mobile health-care information for all: a global challenge. Lancet Glob Health. 2015;3(7):e356-e357. doi: 10.1016/S2214-109X(15)00054-6
6. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi: 10.1136/bmj.39489.470347.AD
7. Lebanova H, Getov I, Grigorov E. Practical tool to assess reliability of web-based medicines information. Med Glas (Zenica). 2014;11(1):221-227.
8. Chalmers I. Underreporting research is scientific misconduct. JAMA. 1990;263(10):1405-1408.
9. Fernandez-Llimos F, Vazquez Gomez I. Information provided by generic and brand-name pharmaceutical manufacturers in response to a request. Pharm World Sci. 2007;29(6):683-687.
10. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53(2):207-216.
11. Arguello B, Salgado TM, Fernandez-Llimos F. Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation. Br J Clin Pharmacol. 2015;79(3):537-544. doi: 10.1111/bcp.12515